You are here
Investor Relations
Financial Information
| Filing date | Form | Description | View |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| SC 13G/A | An amendment to the SC 13G filing |
View HTML | |
| SC 13G/A | An amendment to the SC 13G filing |
View HTML | |
| 4 | Statement of changes in beneficial ownership of securities |
View HTML | |
| 10-K | Annual report which provides a comprehensive overview of the company for the past year |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
| S-3ASR | S-3ASR |
View HTML |
Copyright Morningstar
The Science of Possibility
Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.
Locations
Corporate Headquarters
50 Northern Avenue
Boston, MA 02210
Tel +1(617)-341-6100
Join Us
Giving Back
KALYDECO, the KALYDECO logo, ORKAMBI, the ORKAMBI logo, Vertex and the Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated.
SYMDEKO and the SYMDEKO logo are trademarks of Vertex Pharmaceuticals Incorporated.
All other trademarks referenced herein are the properties of their respective owners.
© 2017 Vertex Pharmaceuticals Incorporated | VXR-US-00-00270 | 04/2017